Multiple sclerosis (MS) is a chronic neurological autoimmune disease; pediatric-onset multiple sclerosis (POMS) represents 5% to 10% of total MS population. Children with POMS may experience attention difficulties due to the disease’s impact on the central nervous system. However, little is known regarding Attention Deficit Hyperactivity Disorder (ADHD) in POMS, and its relation to cognitive performance.
Methods:
A retrospective case review was conducted using medical records of 66 children and adolescent patients diagnosed with POMS between 2012 and 2021 in a MS center of a tertiary medical center. All patients had undergone routine clinical neurological examinations and had been assessed for a diagnosis of ADHD by a department pediatric neurologist. In addition, sociodemographic data, disease-related variables, and cognitive performance were collected.
Results:
Of the 66 patients, 31 (47%) had a diagnosis of ADHD; 29 (44%) had cognitive impairment. Moreover, we identified four different profiles of POMS: those with only ADHD (17, 26%); only cognitive impairment (15, 23%), ADHD and cognitive impairment (14, 21%), and only POMS (20, 30%). A significant difference in disease duration was found among the four profiles [F(3,65) = 8.17, p < .001, η² = 0.29], indicating that patients with ADHD and cognitive impairment were characterized by longer disease duration.
Conclusions:
ADHD may be prominently involved in POMS, even during the early stages of the disease and early diagnosis is crucial in order to provide appropriate interventions and support.
AbeM.SuzukiK.OkadaK.MiuraR.FujiiT.EtsurouM.YamadoriA. (2004). [Normative data on tests for frontal lobe functions: Trail making test, verbal fluency, Wisconsin card sorting test (Keio version)]. No to shinkei= Brain and nerve, 56(7), 567–574.
2.
AchironA.BarakY. (2003). Cognitive impairment in probable multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry, 74(4), 443–446. https://doi.org/10.1136/jnnp.74.4.443
3.
AchironA.ChapmanJ.MagalashviliD.DolevM.LavieM.BercovichE.PolliackM.DonigerG. M.SternY.KhilkevichO.MenascuS.HararaiG.GurevichM.BarakY. (2013). Modeling of cognitive impairment by disease duration in multiple sclerosis: A cross-sectional study. PLoS One, 8(8), 1–10. https://doi.org/10.1371/journal.pone.0071058
4.
AchironA.DonigerG. M.HarelY.Appleboim-GavishN.LavieM.SimonE. S. (2007). Prolonged response times characterize cognitive performance in multiple sclerosis. European Journal of Neurology, 14(10), 1102–1108. https://doi.org/10.1111/j.1468-1331.2007.01909.x
AmatoM. P.GorettiB.GhezziA.HakikiB.NiccolaiC.LoriS.MoiolaL.FalautanoM.ViterboR. G.PattiF.CiliaS.PozzilliC.BianchiV.RoscioM.MartinelliV.ComiG.PortaccioE.TrojanoM. (2014). Neuropsychological features in childhood and juvenile multiple sclerosis: Five-year follow-up. Neurology, 83(16), 1432–1438. https://doi.org/10.1212/WNL.0000000000000885
7.
AmatoM. P.GorettiB.GhezziA.LoriS.ZipoliV.MoiolaL.FalautanoM.De CaroM. F.ViterboR.PattiF.VecchioR.PozzilliC.BianchiV.RoscioM.MartinelliV.ComiG.PortaccioE.TrojanoM. (2010). Cognitive and psychosocial features in childhood and juvenile MS: Two-year follow-up. Neurology, 75(13), 1134–1140. https://doi.org/10.1212/WNL.0b013e3181f4d821
8.
AmatoM. P.GorettiB.GhezziA.LoriS.ZipoliV.PortaccioE.MoiolaL.FalautanoM.De CaroM. F.LopezM.PattiF.VecchioR.PozzilliC.BianchiV.RoscioM.ComiG.TrojanoM. (2008). Cognitive and psychosocial features of childhood and juvenile MS. Neurology, 70(20), 1891–1897. https://doi.org/10.1212/01.wnl.0000312276.23177.fa
AmatoM. P.PonzianiG.PracucciG.BraccoL.SiracusaG.AmaducciL. (1995). Cognitive impairment in early-onset multiple sclerosis. Pattern, predictors, and impact on everyday life in a 4-year follow-up. Archives of Neurology, 52, 168–172. https://doi.org/10.1001/archneur.1995.00540260072019
11.
AmatoM. P.PonzianiG.SiracusaG.SorbiS. (2001). Cognitive dysfunction in early-onset multiple sclerosis: A reappraisal after 10 years. Archives of Neurology, 58, 1602–1606. https://doi.org/10.1001/archneur.58.10.1602
12.
AmatoM. P.PortaccioE.GorettiB.ZipoliV.HakikiB.GianniniM.PastòL.RazzoliniL. (2010). Cognitive impairment in early stages of multiple sclerosis. Neurological Sciences, 31, S211–S214. https://doi.org/10.1007/s10072-010-0376-4
BarkleyR. A. (1997). Behavioral inhibition, sustained attention, and executive functions: Constructing a unifying theory of ADHD. Psychological Bulletin, 121(1), 65–94.
15.
BergerI.SlobodinO.CassutoH. (2017). Usefulness and validity of continuous performance tests in the diagnosis of attention-deficit hyperactivity disorder children. Archives of Clinical Neuropsychology, 32(1), 81–93. https://doi.org/10.1093/arclin/acw101
16.
BobholzJ. A.RaoS. M. (2003). Cognitive dysfunction in multiple sclerosis: A review of recent developments. Current Opinion in Neurology, 16(3), 283–288.
17.
ConnersC. K.SitareniosG.ParkerJ. D.EpsteinJ. N. (1998a). The revised Conners’ Parent Rating Scale (CPRS-R): Factor structure, reliability, and criterion validity. Journal of Abnormal Child Psychology, 26, 257–268. https://doi.org/10.1023/A:1022602400621
18.
ConnersC. K.SitareniosG.ParkerJ. D.EpsteinJ. N. (1998b). Revision and restandardization of the Conners Teacher Rating Scale (CTRS-R): Factor structure, reliability, and criterion validity. Journal of Abnormal Child Psychology, 26, 279–291. https://doi.org/10.1023/A:1022606501530
19.
Del CampoN.ChamberlainS. R.SahakianB. J.RobbinsT. W. (2011). The roles of dopamine and noradrenaline in the pathophysiology and treatment of attention-deficit/hyperactivity disorder. Biological Psychiatry, 69(12), e145–e157. https://doi.org/10.1016/j.biopsych.2011.02.036
20.
DwolatzkyT.WhiteheadV.DonigerG. M.SimonE. S.SchweigerA.JaffeD.ChertkowH. (2003). Validity of a novel computerized cognitive battery for mild cognitive impairment. BMC Geriatrics, 3, 4–12. https://doi.org/10.1186/1471-2318-3-4
21.
EilertsenE. M.GjerdeL. C.KendlerK. S.RøysambE.AggenS. H.GustavsonK.Reichborn-KjennerudT.YstromE. (2019). Development of ADHD symptoms in preschool children: Genetic and environmental contributions. Development and Psychopathology, 31(4), 1299–1305. https://doi.org/10.1017/S0954579418000731
22.
EkmekciO. (2017). Pediatric multiple sclerosis and cognition: A review of clinical, neuropsychologic, and neuroradiologic features. Behavioural Neurology, 2017, 1–11. https://doi.org/10.1155/2017/1463570
23.
GaillardW. D.Hertz-PannierL.MottS. H.BarnettA. S.LeBihanD.TheodoreW. H. (2000). Functional anatomy of cognitive development: fMRI of verbal fluency in children and adults. Neurology, 54(1), 180–185. https://doi.org/10.1212/WNL.54.1.180
24.
GolanD.WilkenJ.DonigerG. M.FrattoT.KaneR.SrinivasanJ.ZarifM.BumsteadB.BuhseM.FafardL.TopalliI.GudesblattM. (2019). Validity of a multi-domain computerized cognitive assessment battery for patients with multiple sclerosis. Multiple Sclerosis and Related Disorders, 30, 154–162. https://doi.org/10.1016/j.msard.2019.01.051
25.
HarelY.KalronA.MenascuS.MagalashviliD.DolevM.DonigerG.SimonE.AchironA. (2019). Cognitive function in multiple sclerosis: A long-term look on the bright side. PLoS One, 14(8), 1–10. https://doi.org/10.1371/journal.pone.0221784
26.
HancockL. M.GaliotoR.SamsonovA.BuschR. M.HermannB.Matias-GuiuJ. A. (2023). A proposed new taxonomy of cognitive phenotypes in multiple sclerosis: The International Classification of Cognitive Disorders in MS (IC-CoDiMS). Multiple Sclerosis Journal, 29(4–5), 615–627.
27.
InstanesJ. T.HalmøyA.EngelandA.HaavikJ.FuruK.KlungsøyrK. (2017). Attention-deficit/hyperactivity disorder in offspring of mothers with inflammatory and immune system diseases. Biological Psychiatry, 81(5), 452–459.
28.
JulianL.SerafinD.CharvetL.AckersonJ.BenedictR.BraatenE.BrownT.O’DonnellE.ParrishJ.PrestonT.ZaccarielloM.BelmanA.ChitnisT.GormanM.NessJ.PattersonM.RodriguezM.WaubantE.Weinstock-GuttmanB.. . .KruppL. B. (2013). Cognitive impairment occurs in children and adolescents with multiple sclerosis: Results from a United States network. Journal of Child Neurology, 28(1), 102–107. https://doi.org/10.1177/0883073812464816
29.
KruppL. B.TardieuM.AmatoM. P.BanwellB.ChitnisT.DaleR. C.GhezziA.HintzenR.KornbergA.PohlD.RostasyK.TenembaumS.WassmerE. (2013). International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: Revisions to the 2007 definitions. Multiple Sclerosis Journal, 19(10), 1261–1267. https://doi.org/10.1177/1352458513484547
30.
KurtzkeJ. F. (1983). Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology, 33(11), 1444–1452. https://doi.org/10.1212/WNL.33.11.1444
LiY.YanX.LiQ.LiQ.XuG.LuJ.YangW. (2023). Prevalence and trends in diagnosed ADHD among US children and adolescents, 2017–2022. JAMA Network Open, 6(10), 1–4. https://doi.org/10.1001/jamanetworkopen.2023.36872
MacAllisterW. S.BelmanA. L.MilazzoM.WeisbrotD. M.ChristodoulouC.ScherlW. F.PrestonT. E.CianciulliC.KruppL. B. (2005). Cognitive functioning in children and adolescents with multiple sclerosis. Neurology, 64(8), 1422–1425. https://doi.org/10.1212/01.WNL.0000158474.24191.BC
35.
MenascuS.KhavkinY.Zilkha-FalbR.DolevM.MagalashviliD.AchironA.GurevichM. (2021). Clinical and transcriptional recovery profiles in pediatric and adult multiple sclerosis patients. Annals of Clinical and Translational Neurology, 8(1), 81–94. https://doi.org/10.1002/acn3.51244
36.
MenascuS.LegardaC.MironS.AchironA. (2018). Brain lesion load and anatomic distribution in patients with juvenile clinically isolated syndrome predicts rapidly advanced to Multiple Sclerosis. Journal of Child Neurology, 33(10), 633–638. https://doi.org/10.1177/0883073818774716
37.
ParrishJ. B.FarooqO.Weinstock-GuttmanB. (2014). Cognitive deficits in pediatric-onset multiple sclerosis: What does the future hold?Neurodegenerative Disease Management, 4(2), 137–146. https://doi.org/10.2217/nmt.14.4
38.
ParrishJ. B.Weinstock-GuttmanB.SmerbeckA.BenedictR. H.YehE. A. (2013). Fatigue and depression in children with demyelinating disorders. Journal of Child Neurology, 28(6), 713–718. https://doi.org/10.1177/0883073812450750
39.
PastòL.PortaccioE.GorettiB.GhezziA.LoriS.HakikiB.GianniniM.RighiniI.RazzoliniL.NiccolaiC.MoiolaL.FalautanoM.SimoneM.ViterboR. G.PattiF.CiliaS.PozzilliC.BianchiV.RoscioM.. . .AmatoM. P. (2016). The cognitive reserve theory in the setting of pediatric-onset multiple sclerosis. Multiple Sclerosis Journal, 22(13), 1741–1749. https://doi.org/10.1177/1352458516629559
40.
PolanczykG.de LimaM. S.HortaB. L.BiedermanJ.RohdeL. A. (2007). The worldwide prevalence of ADHD: A systematic review and metaregression analysis. American Journal of Psychiatry, 164(6), 942–948.
41.
PortaccioE.De MeoE.BellinviaA.AmatoM. P. (2021). Cognitive issues in pediatric multiple sclerosis. Brain Sciences, 11(4), 442. https://doi.org/10.3390/brainsci11040442
42.
PrakashR. S.SnookE. M.LewisJ. M.MotlR. W.KramerA. F. (2008). Cognitive impairments in relapsing-remitting multiple sclerosis: A meta-analysis. Multiple Sclerosis Journal, 14(9), 1250–1261. https://doi.org/10.1177/1352458508095004
43.
RoccaM. A.AbsintaM.AmatoM. P.MoiolaL.GhezziA.VeggiottiP.CapraR.PortaccioE.FiorinoA.PippoloL.PeraM. C.HorsfieldM. A.FaliniA.ComiG.FilippiM. (2014). Posterior brain damage and cognitive impairment in pediatric multiple sclerosis. Neurology, 82(15), 1314–1321. https://doi.org/10.1212/WNL.0000000000000309
44.
SassonE.DonigerG. M.PasternakO.TarraschR.AssafY. (2013). White matter correlates of cognitive domains in normal aging with diffusion tensor imaging. Frontiers in Neuroscience, 7, 32. https://doi.org/10.3389/fnins.2013.00032
45.
SergeantJ. (2000). The cognitive-energetic model: An empirical approach to attention-deficit hyperactivity disorder. Neuroscience and Biobehavioral Reviews, 24(1), 7–12. https://doi.org/10.1016/s0149-7634(99)00060-3
46.
SnyderH. R.MiyakeA.HankinB. L. (2015). Advancing understanding of executive function impairments and psychopathology: Bridging the gap between clinical and cognitive approaches. Frontiers in Psychology, 6, 328.
47.
TammL.LorenR. E. A.PeughJ.CiesielskiH. A. (2021). The association of executive functioning with academic, behavior, and social performance ratings in children with ADHD. Journal of Learning Disabilities, 54(2), 124–138. https://doi.org/10.1177/0022219420961338
48.
ThompsonA. J.BanwellB. L.BarkhofF.CarrollW. M.CoetzeeT.ComiG.CorrealeJ.FazekasF.FilippiM.FreedmanM. S.FujiharaK.GalettaS. L.HartungH. P.KapposL.LublinF. D.MarrieR. A.MillerA. E.MillerD. H.MontalbanX.. . .CohenJ. A. (2018). Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurology, 17(2), 162–173. https://doi.org/10.1016/S1474-4422(17)30470-2
49.
TillC.RacineN.AraujoD.NarayananS.CollinsD. L.Aubert-BrocheB.ArnoldD. L.BanwellB. (2013). Changes in cognitive performance over a 1-year period in children and adolescents with multiple sclerosis. Neuropsychology, 27(2), 210–219. https://doi.org/10.1037/a0031665
50.
TillC.UdlerE.GhassemiR.NarayananS.ArnoldD. L.BanwellB. L. (2012). Factors associated with emotional and behavioral outcomes in adolescents with multiple sclerosis. Multiple Sclerosis Journal, 18(8), 1170–1180. https://doi.org/10.1177/1352458511433918
51.
UlkeC.RullmannM.HuangJ.LuthardtJ.BeckerG. A.PattM.MeyerP. M.TiepoltS.HesseS.SabriO.StraußM. (2019). Adult attention-deficit/hyperactivity disorder is associated with reduced norepinephrine transporter availability in right attention networks: A (S,S)-O-[11C]methylreboxetine positron emission tomography study. Translational Psychiatry, 9(1), 301. https://doi.org/10.1038/s41398-019-0619-y
52.
WeisbrotD.CharvetL.SerafinD.MilazzoM.PrestonT.ClearyR.MoadelT.SeibertM.BelmanA.KruppL. (2014). Psychiatric diagnoses and cognitive impairment in pediatric multiple sclerosis. Multiple Sclerosis Journal, 20(5), 588–593. https://doi.org/10.1177/1352458513504249
53.
WekerleH.LassmannH. (2005). The immunology of inflammatory demyelinating disease. In D. McAlpine & A. Compston (Eds.), McAlpine’s Multiple Sclerosis (Vol. 2006, pp. 491–555). Elsevier Health Sciences.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
